 | LMD | Name: | tetradecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside | Formula: | C26 H50 O11 | SMILES: | O(CCCCCCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | InChi: | InChI=1S/C26H50O11/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-34-25-23(33)21(31)24(18(16-28)36-25)37-26-22(32)20(30)19(29)17(15-27)35-26/h17-33H,2-16H2,1H3/t17-,18-,19-,20+,21-,22-,23-,24-,25-,26-/m1/s1 | Synonyms: | n-Tetradecyl-b-D-maltopyranosid | Definition date: | 2012-06-06 | Last modified: | 2021-03-01 | Release date: | 2012-08-24 | Identifier: | tetradecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside |
|
 | 2L3 | Name: | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | Formula: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m1/s1 | Synonyms: | menadione bisulfite | Definition date: | 2013-11-25 | Last modified: | 2021-03-01 | Release date: | 2014-02-19 | Identifier: | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
 | LN6 | Name: | N~5~-[(1E)-pentanimidoyl]-L-ornithine | Formula: | C10 H21 N3 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])CCCC | InChi: | InChI=1S/C10H21N3O2/c1-2-3-6-9(12)13-7-4-5-8(11)10(14)15/h8H,2-7,11H2,1H3,(H2,12,13)(H,14,15)/t8-/m0/s1 | Synonyms: | N5-(1-iminopentyl)-L-ornithine | Definition date: | 2010-10-20 | Last modified: | 2021-03-01 | Identifier: | N~5~-[(1E)-pentanimidoyl]-L-ornithine |
|
 | 2LB | Name: | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | Formula: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m0/s1 | Synonyms: | menadione bisulfite | Definition date: | 2013-11-26 | Last modified: | 2021-03-01 | Release date: | 2014-02-19 | Identifier: | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
 | 511 | Name: | [1-(4-chlorobenzoyl)-5-methoxy-1H-indol-3-yl]acetic acid | Formula: | C18 H14 Cl N O4 | SMILES: | Clc1ccc(cc1)C(=O)n3c2ccc(OC)cc2c(c3)CC(=O)O | InChi: | InChI=1S/C18H14ClNO4/c1-24-14-6-7-16-15(9-14)12(8-17(21)22)10-20(16)18(23)11-2-4-13(19)5-3-11/h2-7,9-10H,8H2,1H3,(H,21,22) | Synonyms: | 2'-desmethyl-indomethacin | Definition date: | 2012-01-19 | Last modified: | 2021-03-01 | Release date: | 2013-03-06 | Identifier: | [1-(4-chlorobenzoyl)-5-methoxy-1H-indol-3-yl]acetic acid |
|
 | LOA | Name: | (3beta,5beta,9beta)-3-(acetyloxy)cholan-24-oic acid | Formula: | C26 H42 O4 | SMILES: | O=C(O)CCC(C4C3(C(C2C(C1(CCC(OC(=O)C)CC1CC2)C)CC3)CC4)C)C | InChi: | InChI=1S/C26H42O4/c1-16(5-10-24(28)29)21-8-9-22-20-7-6-18-15-19(30-17(2)27)11-13-25(18,3)23(20)12-14-26(21,22)4/h16,18-23H,5-15H2,1-4H3,(H,28,29)/t16-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1 | Synonyms: | Lithocholic acid acetate | Definition date: | 2013-02-08 | Last modified: | 2021-03-01 | Release date: | 2013-06-26 | Identifier: | (3beta,5beta,9beta)-3-(acetyloxy)cholan-24-oic acid |
|
 | LOC | Name: | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide | Formula: | C22 H25 N O6 | SMILES: | O=C(NC3C1=CC(=O)C(OC)=CC=C1c2c(cc(OC)c(OC)c2OC)CC3)C | InChi: | InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 | Synonyms: | COLCHICINE | Definition date: | 2008-08-12 | Last modified: | 2021-03-01 | Identifier: | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide |
|
 | LOP | Name: | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | Formula: | C35 H68 N O8 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCC=C/CCCCCCCC)COP(=O)(OCCN)O)CCCCCCCCCCC | InChi: | InChI=1S/C35H68NO8P/c1-3-5-7-9-11-13-14-15-16-17-18-20-22-24-26-28-35(38)44-33(32-43-45(39,40)42-30-29-36)31-41-34(37)27-25-23-21-19-12-10-8-6-4-2/h15-16,33H,3-14,17-32,36H2,1-2H3,(H,39,40)/b16-15-/t33-/m1/s1 | Synonyms: | LAURYL OLEYL PHOSPHATIDYL ETHANOLAMINE | Definition date: | 2006-02-09 | Last modified: | 2021-03-01 | Identifier: | (1R)-2-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(dodecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate |
|
 | 51V | Name: | 2-methylaniline | Formula: | C7 H9 N | SMILES: | c1cc(C)c(cc1)N | InChi: | InChI=1S/C7H9N/c1-6-4-2-3-5-7(6)8/h2-5H,8H2,1H3 | Synonyms: | o-Toluidine | Definition date: | 2015-07-13 | Last modified: | 2021-03-01 | Release date: | 2016-08-03 | Identifier: | 2-methylaniline |
|
 | 52W | Name: | (3R,3aS,4S,7aS)-3-hydroxyhexahydro-4H-furo[2,3-b]pyran-4-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate | Formula: | C29 H40 N2 O9 S | SMILES: | N(CC(C)C)(S(c1ccc(OC)cc1)(=O)=O)CC(C(Cc2ccccc2)NC(OC4C3C(COC3OCC4)O)=O)O | InChi: | InChI=1S/C29H40N2O9S/c1-19(2)16-31(41(35,36)22-11-9-21(37-3)10-12-22)17-24(32)23(15-20-7-5-4-6-8-20)30-29(34)40-26-13-14-38-28-27(26)25(33)18-39-28/h4-12,19,23-28,32-33H,13-18H2,1-3H3,(H,30,34)/t23-,24+,25-,26-,27-,28-/m0/s1 | Synonyms: | GRL-015 | Definition date: | 2015-07-20 | Last modified: | 2021-03-01 | Release date: | 2016-01-13 | Identifier: | (3R,3aS,4S,7aS)-3-hydroxyhexahydro-4H-furo[2,3-b]pyran-4-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate |
|
 | LPS | Name: | O-{HYDROXY[((2R)-2-HYDROXY-3-{[(1S)-1-HYDROXYPENTADECYL]OXY}PROPYL)OXY]PHOSPHORYL}-L-SERINE | Formula: | C21 H44 N O9 P | SMILES: | O=C(O)C(N)COP(=O)(OCC(O)COC(O)CCCCCCCCCCCCCC)O | InChi: | InChI=1S/C21H44NO9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-20(24)29-15-18(23)16-30-32(27,28)31-17-19(22)21(25)26/h18-20,23-24H,2-17,22H2,1H3,(H,25,26)(H,27,28)/t18-,19+,20-/m1/s1 | Synonyms: | LYSOPHOSPHOTIDYLSERINE | Definition date: | 2003-02-21 | Last modified: | 2021-03-01 | Identifier: | O-[(R)-hydroxy{[(2R)-2-hydroxy-3-{[(1R)-1-hydroxypentadecyl]oxy}propyl]oxy}phosphoryl]-L-serine |
|
 | LPY | Name: | (2R)-2-hydroxy-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl tridecanoate | Formula: | C22 H43 O12 P | SMILES: | P(OC1C(O)C(O)C(O)C(O)C1O)(O)(=O)OCC(O)COC(=O)CCCCCCCCCCCC | InChi: | InChI=1S/C22H43O12P/c1-2-3-4-5-6-7-8-9-10-11-12-16(24)32-13-15(23)14-33-35(30,31)34-22-20(28)18(26)17(25)19(27)21(22)29/h15,17-23,25-29H,2-14H2,1H3,(H,30,31)/t15-,17-,18-,19+,20-,21-,22-/m1/s1 | Synonyms: | sn-1-tridecanoyl-phosphatidylinositol | Definition date: | 2015-01-22 | Last modified: | 2021-03-01 | Release date: | 2015-07-15 | Identifier: | (2R)-2-hydroxy-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl tridecanoate |
|
 | LQQ | Name: | 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE | Formula: | C24 H29 N7 O2 | SMILES: | O=C2N(c1nc(ncc1C(=C2C(=O)C)C)Nc3ncc(cc3)N4CCNCC4)C5CCCC5 | InChi: | InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) | Synonyms: | Palbociclib | Definition date: | 2005-11-28 | Last modified: | 2021-03-01 | Identifier: | 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one |
|
 | 53U | Name: | D-phenylalanyl-N-benzyl-L-prolinamide | Formula: | C21 H25 N3 O2 | SMILES: | O=C(NCc1ccccc1)C3N(C(=O)C(N)Cc2ccccc2)CCC3 | InChi: | InChI=1S/C21H25N3O2/c22-18(14-16-8-3-1-4-9-16)21(26)24-13-7-12-19(24)20(25)23-15-17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15,22H2,(H,23,25)/t18-,19+/m1/s1 | Synonyms: | (2S)-1-((2R)-2-amino-3-phenyl-propanoyl)-N-(phenylmethyl)pyrrolidine-2-carboxamide | Definition date: | 2008-01-08 | Last modified: | 2021-03-01 | Identifier: | D-phenylalanyl-N-benzyl-L-prolinamide |
|
 | 545 | Name: | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-(1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL-PIPERIDIN-2-YL)- ACETIC ACID BUTYL ESTER | Formula: | C21 H33 N3 O9 | SMILES: | O=C(OCCCC)C(NC(=O)C(N)Cc1ccc(O)cc1)C2N(O)CC(O)C(O)(C2O)CO | InChi: | InChI=1S/C21H33N3O9/c1-2-3-8-33-20(30)16(17-18(28)21(31,11-25)15(27)10-24(17)32)23-19(29)14(22)9-12-4-6-13(26)7-5-12/h4-7,14-18,25-28,31-32H,2-3,8-11,22H2,1H3,(H,23,29)/t14-,15-,16-,17-,18-,21-/m0/s1 | Synonyms: | SB-243545 | Definition date: | 2001-07-05 | Last modified: | 2021-03-01 | Identifier: | butyl (2S)-[(2S,3S,4S,5S)-1,3,4,5-tetrahydroxy-4-(hydroxymethyl)piperidin-2-yl](L-tyrosylamino)ethanoate |
|
 | LRD | Name: | 2-[(E)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonic acid | Formula: | C19 H12 Cl2 O5 S | SMILES: | ClC3=CC(=C(/c1ccc(O)c(Cl)c1)c2ccccc2S(=O)(=O)O)C=CC3=O | InChi: | InChI=1S/C19H12Cl2O5S/c20-14-9-11(5-7-16(14)22)19(12-6-8-17(23)15(21)10-12)13-3-1-2-4-18(13)27(24,25)26/h1-10,22H,(H,24,25,26)/b19-12+ | Synonyms: | Chlorophenol Red | Definition date: | 2013-10-23 | Last modified: | 2021-03-01 | Release date: | 2013-10-30 | Identifier: | 2-[(E)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonic acid |
|
 | 54H | Name: | 5'-O-(D-valylsulfamoyl)adenosine | Formula: | C15 H23 N7 O7 S | SMILES: | O=C(NS(=O)(=O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)C(N)C(C)C | InChi: | InChI=1S/C15H23N7O7S/c1-6(2)8(16)14(25)21-30(26,27)28-3-7-10(23)11(24)15(29-7)22-5-20-9-12(17)18-4-19-13(9)22/h4-8,10-11,15,23-24H,3,16H2,1-2H3,(H,21,25)(H2,17,18,19)/t7-,8-,10-,11-,15-/m1/s1 | Synonyms: | 5'-O-(3-Methyl-2-aminobutyrylsulfamoyl) adenosine | Definition date: | 2008-04-01 | Last modified: | 2021-03-01 | Identifier: | 5'-O-(D-valylsulfamoyl)adenosine |
|
 | 54K | Name: | 7-methyl-3H-imidazo[4,5-c]pyridin-4-amine | Formula: | C7 H8 N4 | SMILES: | n1c(c2c(c(c1)C)ncn2)N | InChi: | InChI=1S/C7H8N4/c1-4-2-9-7(8)6-5(4)10-3-11-6/h2-3H,1H3,(H2,8,9)(H,10,11) | Synonyms: | 3-deaza-3-methyladenine | Definition date: | 2015-07-23 | Last modified: | 2021-03-01 | Release date: | 2015-10-28 | Identifier: | 7-methyl-3H-imidazo[4,5-c]pyridin-4-amine |
|
 | 55C | Name: | 2-{[(2E)-3-(naphthalen-2-yl)but-2-enoyl]amino}benzoic acid | Formula: | C21 H17 N O3 | SMILES: | c31ccccc1cc(C(=CC(Nc2ccccc2C(O)=O)=O)C)cc3 | InChi: | InChI=1S/C21H17NO3/c1-14(16-11-10-15-6-2-3-7-17(15)13-16)12-20(23)22-19-9-5-4-8-18(19)21(24)25/h2-13H,1H3,(H,22,23)(H,24,25)/b14-12+ | Synonyms: | BIBR 1532 | Definition date: | 2015-07-27 | Last modified: | 2021-03-01 | Release date: | 2015-09-09 | Identifier: | 2-{[(2E)-3-(naphthalen-2-yl)but-2-enoyl]amino}benzoic acid |
|
 | LSN | Name: | [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol | Formula: | C22 H23 Cl N6 O | SMILES: | CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4n[nH]nn4 | InChi: | InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) | Synonyms: | Losartan | Definition date: | 2017-02-01 | Last modified: | 2021-03-01 | Release date: | 2017-10-25 | Identifier: | [2-butyl-5-chloranyl-3-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol |
|
 | LSP | Name: | (7S)-4,7-DIHYDROXY-10-OXO-3,5,9-TRIOXA-4-PHOSPHAUNDECAN-1-AMINIUM 4-OXIDE | Formula: | C7 H17 N O7 P | SMILES: | O=C(OCC(O)COP(=O)(OCC[NH3+])O)C | InChi: | InChI=1S/C7H16NO7P/c1-6(9)13-4-7(10)5-15-16(11,12)14-3-2-8/h7,10H,2-5,8H2,1H3,(H,11,12)/p+1/t7-/m0/s1 | Synonyms: | 1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | Definition date: | 2006-02-01 | Last modified: | 2021-03-01 | Identifier: | (4S,7S)-4,7-dihydroxy-10-oxo-3,5,9-trioxa-4-phosphaundecan-1-aminium 4-oxide |
|
 | 55Q | Name: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid | Formula: | C38 H57 N5 O7 S | SMILES: | N1(CCCCC1C(=O)NC(C(N(C(C(C)C)CC(OC(C)=O)c3nc(C(=O)NC(CC(C(=O)O)C)Cc2ccccc2)cs3)C)=O)C(CC)C)C | InChi: | InChI=1S/C38H57N5O7S/c1-9-24(4)33(41-35(46)30-17-13-14-18-42(30)7)37(47)43(8)31(23(2)3)21-32(50-26(6)44)36-40-29(22-51-36)34(45)39-28(19-25(5)38(48)49)20-27-15-11-10-12-16-27/h10-12,15-16,22-25,28,30-33H,9,13-14,17-21H2,1-8H3,(H,39,45)(H,41,46)(H,48,49)/t24-,25-,28-,30+,31-,32-,33-/m1/s1 | Synonyms: | Tubulysin M | Definition date: | 2015-07-30 | Last modified: | 2021-03-01 | Release date: | 2016-07-27 | Identifier: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid |
|
 | LSS | Name: | 5'-O-(L-leucylsulfamoyl)adenosine | Formula: | C16 H25 N7 O7 S | SMILES: | O=C(NS(=O)(=O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)C(N)CC(C)C | InChi: | InChI=1S/C16H25N7O7S/c1-7(2)3-8(17)15(26)22-31(27,28)29-4-9-11(24)12(25)16(30-9)23-6-21-10-13(18)19-5-20-14(10)23/h5-9,11-12,16,24-25H,3-4,17H2,1-2H3,(H,22,26)(H2,18,19,20)/t8-,9+,11+,12+,16+/m0/s1 | Synonyms: | 5-O-N-LEUCYL-SULFAMOYLADENOSINE | Definition date: | 2013-01-11 | Last modified: | 2021-03-01 | Release date: | 2013-02-22 | Identifier: | 5'-O-(L-leucylsulfamoyl)adenosine |
|
 | 564 | Name: | 6-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTALENE-2-CARBONYL)-NAPHTALENE-2-CARBOXYLIC ACID | Formula: | C26 H26 O3 | SMILES: | O=C(O)c2ccc1cc(ccc1c2)C(=O)c3ccc4c(c3)C(CCC4(C)C)(C)C | InChi: | InChI=1S/C26H26O3/c1-25(2)11-12-26(3,4)22-15-19(9-10-21(22)25)23(27)18-7-5-17-14-20(24(28)29)8-6-16(17)13-18/h5-10,13-15H,11-12H2,1-4H3,(H,28,29) | Synonyms: | CD564 | Definition date: | 2000-08-08 | Last modified: | 2021-03-01 | Identifier: | 6-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]naphthalene-2-carboxylic acid |
|
 | LT5 | Name: | (1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol | Formula: | C9 H10 F3 N O | SMILES: | FC(F)(F)c1cccc(c1)C(O)CN | InChi: | InChI=1S/C9H10F3NO/c10-9(11,12)7-3-1-2-6(4-7)8(14)5-13/h1-4,8,14H,5,13H2/t8-/m0/s1 | Synonyms: | 3-Trifluoromethyl phenylethanolamine | Definition date: | 2009-05-08 | Last modified: | 2021-03-01 | Identifier: | (1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol |
|